This paper is in the following e-collection/theme issue:

Innovations in Clinical Trials and Research Data Management (73) Vaccination and Immunization in the Digital Age (347) Health Services in Resource-Poor Settings and LMICs (376)

Published on in Vol 23, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28573, first published .
Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study

Authors of this article:

Trésor Zola Matuvanga1, 2, 3 Author Orcid Image ;   Ginger Johnson4 Author Orcid Image ;   Ynke Larivière2, 3 Author Orcid Image ;   Emmanuel Esanga Longomo5 Author Orcid Image ;   Junior Matangila1 Author Orcid Image ;   Vivi Maketa1 Author Orcid Image ;   Bruno Lapika6 Author Orcid Image ;   Patrick Mitashi1 Author Orcid Image ;   Paula Mc Kenna7 Author Orcid Image ;   Jessie De Bie2, 3 Author Orcid Image ;   Jean-Pierre Van Geertruyden2 Author Orcid Image ;   Pierre Van Damme3 Author Orcid Image ;   Hypolite Muhindo Mavoko1 Author Orcid Image
Article Authors Cited by (8) Tweetations (3) Metrics

Journals

  1. Okello E, Ayieko P, Kwena Z, Nanyonjo G, Bahemuka U, Price M, Bukusi E, Hashim R, Nakamanya S, Okech B, Kuteesa M, Oketch B, Ssetaala A, Ruzagira E, Kidega W, Fast P, Kibengo F, Grosskurth H, Seeley J, Kapiga S. Acceptability and applicability of biometric iris scanning for the identification and follow up of highly mobile research participants living in fishing communities along the shores of Lake Victoria in Kenya, Tanzania, and Uganda. International Journal of Medical Informatics 2023;172:105018 View
  2. Zola Matuvanga T, Larivière Y, Lemey G, De Bie J, Milolo S, Meta R, Esanga E, Vermeiren P, Thys S, Van geertruyden J, Van Damme P, Maketa V, Matangila J, Mitashi P, Muhindo-Mavoko H. Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned. Vaccine 2022;40(25):3470 View
  3. Larivière Y, Zola T, Stoppie E, Maketa V, Matangila J, Mitashi P, De Bie J, Muhindo-Mavoko H, Van geertruyden J, Van Damme P. Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol. BMJ Open 2021;11(9):e046835 View
  4. Mc Kenna P, Broadfield L, Willems A, Masyn S, Pattery T, Draghia-Akli R. Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparedness. Expert Review of Vaccines 2023;22(1):243 View
  5. Mittermaier M, Venkatesh K, Kvedar J. Digital health technology in clinical trials. npj Digital Medicine 2023;6(1) View
  6. Wells A, Usman A. Privacy and biometrics for smart healthcare systems: attacks, and techniques. Information Security Journal: A Global Perspective 2024;33(3):307 View
  7. Larivière Y, Matuvanga T, Lemey G, Osang'ir B, Vermeiren P, Milolo S, Meta R, Kimbulu P, Esanga E, Matangila J, Van geertruyden J, Van Damme P, Maketa V, Muhindo-Mavoko H, Mitashi P. Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned. Vaccine 2023;41(51):7587 View